Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Health Behav. 2010 May-Jun;34(3):267-74.

Translational medication development for nicotine addiction.

Author information

  • 1Tobacco Control Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20852, USA. gmorgan@nih.gov

Abstract

OBJECTIVE:

To review the current state of the science in medication development for nicotine dependence and to identify important areas for future research.

METHODS:

The National Cancer Institute and the National Institute on Drug Abuse convened a conference focused on translational approaches to the development, evaluation, and delivery of medications for the treatment of tobacco dependence.

RESULTS:

Future research directions include investigations of the efficacy of novel compounds and new applications for existing medications; pharmacogenetic trials of nicotine dependence treatments; and studies of the molecular, neural, and behavioral mechanisms of action of efficacious medications.

CONCLUSIONS:

Medication development for the treatment of tobacco dependence remains a scientific and public health priority.

PMID:
20001184
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Ingenta plc
    Loading ...
    Write to the Help Desk